The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...

Indian paediatric rheumatologists discuss early diagnosis and management of rheumatic disorders in children to prevent organ ...

Several known risk factors of Dermatomyositis (DM) include female sex, genetics, ultraviolet radiation, prior respiratory disease, viral and bacterial infections, medications, and pollutants and ...

FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET™ clinical development program since ACR ...

Research analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Cabaletta Bio in a research note issued to investors on Tuesday, April 1st. HC Wainwright analyst D. Tsao ...

The Ridin’ For Kids Foundation has announced the child that will be benefiting from their 2025 fundraiser event.

Research analysts at HC Wainwright raised their Q1 2025 EPS estimates for shares of Cabaletta Bio in a note issued to investors on Tuesday, April 1st. HC Wainwright analyst D. Tsao now anticipates ...

In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire David Einhorn. David Einhorn is a highly ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.